Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. (Q53912470)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
scientific article

    Statements

    Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Timothy Cox
    0 references
    Sonja van Weely
    0 references
    Terry Butters
    0 references
    Raymond Dwek
    0 references
    Chris Moyses
    0 references
    Irene Gow
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit